Precision Liver Study Completes 1-Year Recruitment of Nearly 1,000 Participants Using Existing NHS Data

Summary

Predictive Health Intelligence and Sano Genetics have completed recruitment for the LiveWell study, enrolling 996 participants from a single NHS site in under a year by leveraging PHI’s hepatoSIGHT case‑finding software and existing NHS blood‑test data. The digital workflow enabled e‑consent, at‑home genetic testing and remote FibroScan booking, achieving a 95% engagement rate and 76% conversion to sign‑up. The initiative, supported by Somerset NHS Foundation Trust, Tawazun Health and Innovate UK, demonstrates a scalable, data‑driven model that can dramatically accelerate participant recruitment for precision medicine trials, addressing a major cause of trial delays.